Skip to content

Colesevelam

Welchol, Cholestagel (colesevelam hydrochloride) is a small molecule pharmaceutical. Colesevelam hydrochloride was first approved as Welchol on 2000-05-26. It is used to treat coronary artery disease, diarrhea, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia amongst others in the USA. It has been approved in Europe to treat hypercholesterolemia. Welchol's patent is valid until 2022-04-17 (FDA).
Trade Name Cholestagel
Common Name Colesevelam
Indication coronary artery disease, diarrhea, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia, pseudomembranous enterocolitis, type 2 diabetes mellitus
Drug Class
Colesevelam
Get full access now